| Description of Property | Date Acquired | Cost or Other Basis | Prior Years' Depreciation | Computation Method | Rate / Life (# of years) |
Current Year's Depreciation Expense | Net Investment Income | Adjusted Net Income | Cost of Goods Sold Not Included |
|---|
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| NOVARTIS A G SPON ADR | 3,387,975 | 3,545,469 |
| AVADEL PHARMACEUTICA | 425,510 | 334,000 |
| ROCHE HLDG AG | 1,841,712 | 2,595,328 |
| ALCON | 440,021 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| HALL CAPITAL | AT COST | 355,125 | 702,000 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| NJ FILING FEE |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT FEES | 3,434 | 3,434 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES | 50,395 | 50,395 | ||
| FEDERAL TAXES | 2,800 |